Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Biology Open
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Biology Open

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
Research Article
McArdle disease does not affect skeletal muscle fibre type profiles in humans
Tertius Abraham Kohn, Timothy David Noakes, Dale Elizabeth Rae, Juan Carlos Rubio, Alfredo Santalla, Gisela Nogales-Gadea, Tomas Pinós, Miguel A. Martín, Joaquin Arenas, Alejandro Lucia
Biology Open 2014 3: 1224-1227; doi: 10.1242/bio.20149548
Tertius Abraham Kohn
1UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ta.kohn@uct.ac.za
Timothy David Noakes
1UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale Elizabeth Rae
1UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Carlos Rubio
2Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfredo Santalla
3Department of Sport Science, Universidad Pablo de Olavide, 41013 Seville, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisela Nogales-Gadea
4Neuromuscular Diseases Unit, Institut de Recerca del Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, 08193 Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Pinós
5Departament de Patologia Mitocondrial i Neuromuscular, Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, 08193 Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel A. Martín
2Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joaquin Arenas
2Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Lucia
2Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
6European University of Madrid, 28670 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF
Loading

ABSTRACT

Patients suffering from glycogen storage disease V (McArdle disease) were shown to have higher surface electrical activity in their skeletal muscles when exercising at the same intensity as their healthy counterparts, indicating more muscle fibre recruitment. To explain this phenomenon, this study investigated whether muscle fibre type is shifted towards a predominance in type I fibres as a consequence of the disease. Muscle biopsies from the Biceps brachii (BB) (n = 9) or Vastus lateralis (VL) (n = 8) were collected over a 13-year period from male and female patients diagnosed with McArdle disease, analysed for myosin heavy chain (MHC) isoform content using SDS-PAGE, and compared to healthy controls (BB: n = 3; VL: n = 10). All three isoforms were expressed and no difference in isoform expression in VL was found between the McArdle patients and healthy controls (MHC I: 33±19% vs. 43±7%; MHC IIa: 52±9% vs. 40±7%; MHC IIx: 15±18% vs. 17±9%). Similarly, the BB isoform content was also not different between the two groups (MHC I: 33±14% vs. 30±11%; MHC IIa: 46±17% vs. 39±5%; MHC IIx: 21±13% vs. 31±14%). In conclusion, fibre type distribution does not seem to explain the higher surface EMG in McArdle patients. Future studies need to investigate muscle fibre size and contractility of McArdle patients.

INTRODUCTION

McArdle patients suffer from glycogen storage disease V and have limited endogenous glycogen for use during exercise. They find exercise difficult and fatigue quickly, presumably since they initially rely on blood glucose from exogenous sources for fuel. They often, however, report a “second-wind” effect, coinciding with the mobilisation of free-fatty acids for fuel (Lucia et al., 2008; van Adel and Tarnopolsky, 2009). As a result, many McArdle patients avoid exercise, or are advised that exercise is contra-indicated for their condition, which may inadvertently decrease their quality of life. A recent study found that patients suffering from McArdle disease produced less force, fatigued faster, and surprisingly recorded almost three times as much surface electrical activity in their skeletal muscles (measured by electromyography) compared to healthy controls exercising at the same intensity (Rae et al., 2010). Surface EMG activity correlates well with the number of active motor units (Moritani and Muro, 1987), and are therefore good proxies for muscle fibre recruitment. Although some evidence exist that muscle fibre type correlates with EMG activity in vitro, it is still unclear whether this holds true in vivo (Farina, 2008; Kupa et al., 1995; von Tscharner and Nigg, 2008). In theory, this should hold true, but current techniques in pinpointing EMG activities to a particular fibre or fibre type is still in its infancy. Nevertheless, Rae et al. (Rae et al., 2010) suggested that this excessive muscle recruitment might be attributed to altered contractile properties of the diseased muscle, perhaps compounding the exercise intolerance experienced by McArdle patients.

Muscle fibre type plays an important role in determining the amount of force and power output a muscle can produce, as well as its resistance to fatigue. It is well documented that type I fibres produce less force and power, have slower contraction speeds, but are more resistant to fatigue than type IIA muscle fibres (Essén-Gustavsson and Henriksson, 1984; Kohn and Noakes, 2013). The fatigue resistance is primarily attributed to abundant mitochondria found in type I fibres and its ability to utilise fat as a fuel source to generate ATP for muscle contraction (Bottinelli, 2001; Pette, 1985). Type IIA fibres produce force and power levels below that of type IIX fibres, but significantly higher than type I fibres, have high mitochondrial content, rely on glycogen and fat stores for ATP replenishment, and withstand fatigue for longer periods of time than type IIX fibres (Pette, 1985). It is well known that endurance athletes have predominantly type I and IIA fibres in their Vastus lateralis (VL) muscle, with high mitochondrial numbers (Essén-Gustavsson and Henriksson, 1984; Kohn et al., 2007b). Sedentary individuals and sprinters have a greater proportion of type IIX muscle fibres, but rarely more than their type I or type IIA fibres (Andersen et al., 1994; Kohn et al., 2007a). Diseases, such as Duchene's muscular dystrophy, was shown to shift the fibre type profile to type I and IIA, even when they also struggle to perform exercise (Fink et al., 1990). To date, very little data exist surrounding muscle fibre type of McArdle patients, specifically whether this disease affects overall fibre type composition.

This study therefore aimed to determine muscle fibre type composition in biopsies from the Biceps brachii (BB) or the VL from McArdle patients, and compare it to healthy controls. The hypothesis was that McArdle patients would have a predominance of type I muscle fibres and significantly more than their healthy counterparts, resulting from an adaptation to rely primarily on fat as a fuel source, due to their inability to utilise their glycogen stores.

RESULTS AND DISCUSSION

To our knowledge, this is the first study reporting the muscle fibre type composition in patients with McArdle disease. The main finding is that McArdle patients had similar fibre type profiles as controls.

Three MHC isoforms (I, IIa and IIx) were found in the McArdle and control samples. The MHC isoforms were separated and identified in healthy control samples using the SDS-PAGE technique and corresponded to (top to bottom) MHC IIx, MHC IIa and MHC I (Fig. 1). This method is well characterised and provides good estimates of relative muscle fibre type from biopsies (Andersen et al., 1994; Curry et al., 2012; Kohn et al., 2007b). No additional bands were detected in control and McArdle samples that may indicate the expression of the IIb, neonatal or embryonic isoforms, as is found in low quantities in regenerating fibres due to exercise or disease (Bottinelli, 2001; D'Antona et al., 2003; Fink et al., 1990; Schiaffino and Reggiani, 1996; Williams et al., 1993).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1. Separation of the myosin heavy chain (MHC) isoforms into three distinct bands using SDS-PAGE of a control and two McArdle patients.

In each well, a total of 1 µg protein and 2.5 µg protein were loaded in the top and bottom gels, respectively.

As McArdle disease is rare [∼1 in 170 000 people in Spain (Lucia et al., 2012)], the patient's data and biopsies were collected over a 13-year period, from both males and females, with a wide age range (17 to 76 years) and biopsies were taken non-intentionally from two muscle groups (VL and BB). Given that the data had to be grouped by muscle for analysis, the groups are heterogeneous, the sample size relatively small and thus interpretation limited.

The MHC isoform content of VL muscle of McArdle patients and healthy controls were not different (MHC I: 33 ± 19% vs. 41 ± 9%; MHC IIa: 52 ± 9% vs. 43 ± 7%; MHC IIx: 15 ± 18% vs. 16 ± 9%) and was also the case for the BB muscle (MHC I: 33 ± 14% vs. 29 ± 11%; MHC IIa: 46 ± 17% vs. 39 ± 5%; MHC IIx: 21 ± 13% vs. 32 ± 14%) (Fig. 2). The relative fibre type distributions obtained in this study are well in range with published data on sedentary and recreationally active individuals. For young (i.e. 20 to 30 years of age), inactive to recreationally active individuals, the range in fibre type distribution in the VL is approximately between 35 and 60% MHC I and 35 to 50% MHC IIa. The amount of MHC IIx expressed in this muscle is not particularly high, and can constitute approximately 25% of the total MHC isoform composition (Klitgaard et al., 1990b; Kohn et al., 2011; Monemi et al., 1999). Previous research has found a weak, yet significant positive correlation between the percentage type I muscle fibres and age (Gouzi et al., 2013). Unfortunately, with the large range in standard deviation and overlap between the 19 studies evaluated in the study by Gouzi et al. (Gouzi et al., 2013), the average type I profile of the elderly ranged from 45 to 55%. It therefore suggests that age has a less important role in determining fibre type. In the present study, there was no relationship found between any of the MHC isoforms from the two muscle groups and age.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2. Myosin heavy chain isoform distribution in (A) Biceps brachii and (B) Vastus lateralis from healthy participants (closed circles) and patients diagnosed with McArdle disease (open circles).

Values from the literature (bars) are included for both muscle groups as reference points (Klitgaard et al., 1990b). Where appropriate, data are presented as mean ± SD.

It is well known that endurance athletes have a predominance in MHC I and IIa isoforms and very little to no MHC IIx in their VL, whereas resistance athletes may present with values similar to inactive individuals (D'Antona et al., 2006; Kohn et al., 2007b). Thus, physical activity levels seem to play a greater role in determining the fibre type profile of a muscle. The MHC isoform content of the BB from the controls and McArdle patients were similar in range and agreed with data from Klitgaard et al. (Klitgaard et al., 1990a) (included in Fig. 2), Monemi et al. (Monemi et al., 1999) and Elder et al. (Elder et al., 1982). It has to be emphasised though, that gender, age and trained status seems to play a greater role in determining the size of the muscle fibre. The McArdle patients of this study were encouraged by their respective physicians to refrain from physical activity except for those necessary for daily living. The patients were therefore untrained and sedentary (Maté-Muñoz et al., 2007).

Interestingly, isoform profiles for the McArdle patients were similar for both muscles analysed, with the MHC I and IIa being almost double that of MHC IIx. In contrast, the BB of controls tended to have an equal distribution between the three isoforms, whereas the VL predominantly expressed MHC I and IIa.

Unfortunately, the biopsy samples from this study could not be used to determine cross-sectional area of individual muscle fibres due to the long-term storage thereof. This would have been useful to help account for the higher EMG activity at the same workload observed previously (Rae et al., 2010). However, it seems that fibre diameter of only type I fibres are affected by McArdle disease, leaving the type II fibres unchanged (Felice et al., 1996). In contrast, patients with Duchene's muscular dystrophy have a predominance of type I and IIA fibres, with very few to no type IIX fibres (Fink et al., 1990). Thus, it could be argued that, because fibre type in McArdle patients is not affected, and neither is the type II fibre diameters, as proposed by previous research, the contractility of individual fibres may be affected. It is well known that contractility is affected by fibre diameter and the latter affected by exercise type (Bottinelli, 2001). For example, resistance training increases muscle fibre diameters, but normalised force stays the same in single fibres (Shoepe et al., 2003). Endurance exercise, on the other hand, tends to decrease fibre size, but normalised force increases after training (Trappe et al., 2006). Other factors such as myofibrillar concentration (i.e. myosin and actin), myosin light chains and Ca2+ sensitivity could affect the performance of single fibres (Bottinelli, 2001; Ottenheijm et al., 2011).

Limitations of the present study are: (i) small sample size for the control BB muscle (n  =  3) and overall power of the statistical analyses, (ii) unknown biopsy location and depth for certain individuals, (iii) no histology available when analyses were performed.

With regards to the small sample size, this study was unable to obtain more biopsies from healthy individuals from the BB. As this muscle is considerably smaller than the VL, the norm today is to perform most biopsies from the latter. Therefore, a limited number of studies exist in the current literature concerning biopsies from the BB. For both muscle groups, the sample sizes were low, and therefore affected the power of the statistical analyses. Using only the MHC I of the VL (percentage ± SD, n), the overall power was calculated as 0.195 with an alpha of 0.05. By using the same data but increasing the samples size to 33 per group, the power only increased to 0.213. To obtain a significant power (0.90), we calculated the number of participants in each group and amounted to 79 subjects per group, which is an unrealistic number in terms of data collection.

It is well known that the location and depth of the biopsy can significantly influence the fibre type composition (Elder et al., 1982; Kohn and Myburgh, 2007). Unfortunately, it is not clear where the exact location of the biopsy sites were for the McArdle patients. As most neurologists prefer the open biopsy technique, it was assumed that the McArdle biopsies (VL and BB) and the BB from the three controls were performed using the open biopsy technique, which will mostly sample superficially. On the other hand, the control VL biopsies were all obtained using the percutaneous suction assisted technique at a standard depth of 2 cm. Nevertheless, the data from the present study for VL and BB falls well within those obtained for the control participants, as well as the current literature. If the proposed hypothesis were true, a predominance in type I fibres would have been observed in McArdle patients, irrespective of biopsy location.

In conclusion, the data from this study suggested that fibre type distribution does not explain the higher surface EMG in McArdle patients. The skeletal muscle groups (VL and BB) of the male and female McArdle patients used in this study expresses a normal range for each MHC isoform compared to healthy individuals. These data support the suggestion that altered single muscle fibre contractility, fibre diameters or other proteins forming part of the contractile apparatus may partly account for the abnormal muscle recruitment previously observed in McArdle patients (Rae et al., 2010).

MATERIALS AND METHODS

Participants

Muscle samples from McArdle patients analysed in this study were collected as part of a larger study, the details of which have been published previously (Maté-Muñoz et al., 2007). Written informed consent was obtained from these patients that a part of the tissue could be used for research purposes and was approved by the Ethics Committee (Hospital 12 de Octubre, Madrid, Spain). Muscle biopsies were collected from 17 patients (8 male, 9 female, age: 41 ± 18 years) diagnosed with McArdle disease over a 13-year period. VL biopsies (3 male, 5 female, mean age: 48 ± 19 years) or BB biopsies (5 male, 4 female, mean age: 35 ± 16 years) were rapidly frozen in liquid nitrogen and stored at −80°C. VL biopsies from 10 recreationally active males (mean age: 25 ± 2) and BB biopsies from two males and one female (age: 35 ± 10), forming part of previous studies, served as healthy control. Descriptive statistics of the participants are listed in Table 1.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1. Descriptive data of healthy control participants and McArdle patients

McArdle disease was diagnosed by genetic analysis and, in most cases, also confirmed by undetectable myophosphorylase activity and negative myophosphorylase histochemical staining in the muscle biopsies, as previously published (Lucia et al., 2008; Lucia et al., 2012).

Relative muscle fibre type quantification

The myosin heavy chain isoform content of the muscle samples was separated using SDS-PAGE, as described in detail (Kohn et al., 2011). Electrophoresis was carried out at 70 V for 4 hours at 4°C, followed by 275 V for 20 hours. Gels were silver stained, scanned and the densitometric profile of the bands determined (Fig. 1) (Un-Scan-It, Silk Scientific Inc, Utah). Each sample was twice electrophoresed, the first at a total concentration of 1 µg and the second at 2.5 µg to ensure adequate detection of the three isoforms and any additional bands that could correspond to the embryonic, neonatal or the MHC IIb isoform.

Statistical analyses

Data are presented as mean ± standard deviation and subjected to a non-parametric ANOVA (Kruskal-Wallis test) and a Dunn's multiple comparisons post-hoc test (GraphPad Prism). Relationships were determined using the non-parametric Spearman r correlation coefficient. Significance was set at P < 0.05.

List of abbreviations

BB, Biceps brachii; EMG, Electromyographic; MHC, Myosin heavy chain; VL, Vastus lateralis.

Acknowledgements

The authors would sincerely like to thank the participants for their contribution towards the study.

Funding

This study was funded partly by a grant awarded to TDN from the National Research Foundation of South Africa (grant no: CPR20110715000020922). TAK is a recipient of the Tim and Marilyn Noakes Sports Science Postdoctoral Fellowship. GNG is supported by FIS CD10/00027 grants from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain. MAM and AL are participants in the EU project, EUROMAC and supported by FIS granting (grant no: PS12/00194). Funding Body: Executive Agency for Health and Consumers. European Union Ares no. 318081. JCR was supported by a contract from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria CA05/0039.

Footnotes

  • Author Contributions T.A.K. performed the experiments. T.A.K., T.D.N. and D.E.R. analysed the data. A.L., J.A., M.A.M. and T.P. contributed to the conception or design of the work. G.N.-G., J.C.R. and A.S. contributed to the acquisition of data. A.L. drafted the manuscript. T.A.K., T.D.N. and D.E.R. prepared the manuscript. A.L., J.A., M.A.M., T.P., G.N.-G., J.C.R. and A.S. revised the manuscript.

  • Competing interests The authors have no competing interests to declare.

  • Received July 18, 2014.
  • Accepted October 11, 2014.
  • © 2014. Published by The Company of Biologists Ltd

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

REFERENCES

  1. ↵
    1. Andersen J. L.,
    2. Klitgaard H.,
    3. Saltin B.
    (1994). Myosin heavy chain isoforms in single fibres from m. vastus lateralis of sprinters: influence of training. Acta Physiol. Scand. 151, 135–142. doi:10.1111/j.1748-1716.1994.tb09730.x
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Bottinelli R.
    (2001). Functional heterogeneity of mammalian single muscle fibres: do myosin isoforms tell the whole story? Pflugers Arch. 443, 6–17. doi:10.1007/s004240100700
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Curry J. W.,
    2. Hohl R.,
    3. Noakes T. D.,
    4. Kohn T. A.
    (2012). High oxidative capacity and type IIx fibre content in springbok and fallow deer skeletal muscle suggest fast sprinters with a resistance to fatigue. J. Exp. Biol. 215, 3997–4005. doi:10.1242/jeb.073684
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. D'Antona G.,
    2. Pellegrino M. A.,
    3. Adami R.,
    4. Rossi R.,
    5. Carlizzi C. N.,
    6. Canepari M.,
    7. Saltin B.,
    8. Bottinelli R.
    (2003). The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J. Physiol. 552, 499–511. doi:10.1113/jphysiol.2003.046276
    OpenUrlCrossRefPubMed
  5. ↵
    1. D'Antona G.,
    2. Lanfranconi F.,
    3. Pellegrino M. A.,
    4. Brocca L.,
    5. Adami R.,
    6. Rossi R.,
    7. Moro G.,
    8. Miotti D.,
    9. Canepari M.,
    10. Bottinelli R.
    (2006). Skeletal muscle hypertrophy and structure and function of skeletal muscle fibres in male body builders. J. Physiol. 570, 611–627. doi:10.1113/jphysiol.2005.101642
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Elder G. C.,
    2. Bradbury K.,
    3. Roberts R.
    (1982). Variability of fiber type distributions within human muscles. J. Appl. Physiol. 53, 1473–1480.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Essén-Gustavsson B.,
    2. Henriksson J.
    (1984). Enzyme levels in pools of microdissected human muscle fibres of identified type. Adaptive response to exercise. Acta Physiol. Scand. 120, 505–515. doi:10.1111/j.1748-1716.1984.tb07414.x
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Farina D.
    (2008). Counterpoint: spectral properties of the surface EMG do not provide information about motor unit recruitment and muscle fiber type. J. Appl. Physiol. 105, 1673–1674. doi:10.1152/japplphysiol.90598.2008a
    OpenUrlFREE Full Text
  9. ↵
    1. Felice K. J.,
    2. Grunnet M. L.,
    3. Sima A. A.
    (1996). Selective atrophy of type 1 muscle fibers in McArdle's disease. Neurology 47, 581–583. doi:10.1212/WNL.47.2.581
    OpenUrlCrossRef
  10. ↵
    1. Fink R. H.,
    2. Stephenson D. G.,
    3. Williams D. A.
    (1990). Physiological properties of skinned fibres from normal and dystrophic (Duchenne) human muscle activated by Ca2+ and Sr2+. J. Physiol. 420, 337–353.
    OpenUrlPubMedWeb of Science
  11. ↵
    1. Gouzi F.,
    2. Maury J.,
    3. Molinari N.,
    4. Pomiès P.,
    5. Mercier J.,
    6. Préfaut C.,
    7. Hayot M.
    (2013). Reference values for vastus lateralis fiber size and type in healthy subjects over 40 years old: a systematic review and metaanalysis. J. Appl. Physiol. 115, 346–354. doi:10.1152/japplphysiol.01352.2012
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Klitgaard H.,
    2. Bergman O.,
    3. Betto R.,
    4. Salviati G.,
    5. Schiaffino S.,
    6. Clausen T.,
    7. Saltin B.
    (1990a). Co-existence of myosin heavy chain I and IIa isoforms in human skeletal muscle fibres with endurance training. Pflugers Arch. 416, 470–472. doi:10.1007/BF00370757
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Klitgaard H.,
    2. Mantoni M.,
    3. Schiaffino S.,
    4. Ausoni S.,
    5. Gorza L.,
    6. Laurent-Winter C.,
    7. Schnohr P.,
    8. Saltin B.
    (1990b). Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol. Scand. 140, 41–54. doi:10.1111/j.1748-1716.1990.tb08974.x
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Kohn T. A.,
    2. Myburgh K. H.
    (2007). Regional specialization of rat quadriceps myosin heavy chain isoforms occurring in distal to proximal parts of middle and deep regions is not mirrored by citrate synthase activity. J. Anat. 210, 8–18. doi:10.1111/j.1469-7580.2007.00661.x
    OpenUrlCrossRefPubMed
  15. ↵
    1. Kohn T. A.,
    2. Noakes T. D.
    (2013). Lion (Panthera leo) and caracal (Caracal caracal) type IIx single muscle fibre force and power exceed that of trained humans. J. Exp. Biol. 216, 960–969. doi:10.1242/jeb.078485
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Kohn T. A.,
    2. Essen-Gustavsson B.,
    3. Myburgh K. H.
    (2007a). Exercise pattern influences skeletal muscle hybrid fibers of runners and nonrunners. Med. Sci. Sports Exerc. 39, 1977–1984. doi:10.1249/mss.0b013e3181453546
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Kohn T. A.,
    2. Essén-Gustavsson B.,
    3. Myburgh K. H.
    (2007b). Do skeletal muscle phenotypic characteristics of Xhosa and Caucasian endurance runners differ when matched for training and racing distances? J. Appl. Physiol. 103, 932–940. doi:10.1152/japplphysiol.01221.2006
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Kohn T. A.,
    2. Burroughs R.,
    3. Hartman M. J.,
    4. Noakes T. D.
    (2011). Fiber type and metabolic characteristics of lion (Panthera leo), caracal (Caracal caracal) and human skeletal muscle. Comp. Biochem. Physiol. 159A, 125–133. doi:10.1016/j.cbpa.2011.02.006
    OpenUrlCrossRef
  19. ↵
    1. Kupa E. J.,
    2. Roy S. H.,
    3. Kandarian S. C.,
    4. De Luca C. J.
    (1995). Effects of muscle fiber type and size on EMG median frequency and conduction velocity. J. Appl. Physiol. 79, 23–32.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Lucia A.,
    2. Nogales-Gadea G.,
    3. Pérez M.,
    4. Martín M. A.,
    5. Andreu A. L.,
    6. Arenas J.
    (2008). McArdle disease: what do neurologists need to know? Nat. Clin. Pract. Neurol. 4, 568–577. doi:10.1038/ncpneuro0913
    OpenUrlCrossRefPubMed
  21. ↵
    1. Lucia A.,
    2. Ruiz J. R.,
    3. Santalla A.,
    4. Nogales-Gadea G.,
    5. Rubio J. C.,
    6. García-Consuegra I.,
    7. Cabello A.,
    8. Pérez M.,
    9. Teijeira S.,
    10. Vieitez I.
    et al. (2012). Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J. Neurol. Neurosurg. Psychiatry 83, 322–328. doi:10.1136/jnnp-2011-301593
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Maté-Muñoz J. L.,
    2. Moran M.,
    3. Pérez M.,
    4. Chamorro-Viña C.,
    5. Gómez-Gallego F.,
    6. Santiago C.,
    7. Chicharro L.,
    8. Foster C.,
    9. Nogales-Gadea G.,
    10. Rubio J. C.
    et al. (2007). Favorable responses to acute and chronic exercise in McArdle patients. Clin. J. Sport Med. 17, 297–303. doi:10.1097/JSM.0b013e3180f6168c
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Monemi M.,
    2. Kadi F.,
    3. Liu J. X.,
    4. Thornell L. E.,
    5. Eriksson P. O.
    (1999). Adverse changes in fibre type and myosin heavy chain compositions of human jaw muscle vs. limb muscle during ageing. Acta Physiol. Scand. 167, 339–345. doi:10.1046/j.1365-201x.1999.00625.x
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Moritani T.,
    2. Muro M.
    (1987). Motor unit activity and surface electromyogram power spectrum during increasing force of contraction. Eur. J. Appl. Physiol. 56, 260–265. doi:10.1007/BF00690890
    OpenUrlCrossRefWeb of Science
  25. ↵
    1. Ottenheijm C. A. C.,
    2. Lawlor M. W.,
    3. Stienen G. J. M.,
    4. Granzier H.,
    5. Beggs A. H.
    (2011). Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Hum. Mol. Genet. 20, 2015–2025. doi:10.1093/hmg/ddr084
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Pette D.
    (1985). Metabolic heterogeneity of muscle fibres. J. Exp. Biol. 115, 179–189.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Rae D. E.,
    2. Noakes T. D.,
    3. San Juan A. F.,
    4. Pérez M.,
    5. Nogales-Gadea G.,
    6. Ruiz J. R.,
    7. Morán M.,
    8. Martín M. A.,
    9. Andreu A. L.,
    10. Arenas J.
    et al. (2010). Excessive skeletal muscle recruitment during strenuous exercise in McArdle patients. Eur. J. Appl. Physiol. 110, 1047–1055. doi:10.1007/s00421-010-1585-5
    OpenUrlCrossRefPubMed
  28. ↵
    1. Schiaffino S.,
    2. Reggiani C.
    (1996). Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76, 371–423.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Shoepe T. C.,
    2. Stelzer J. E.,
    3. Garner D. P.,
    4. Widrick J. J.
    (2003). Functional adaptability of muscle fibers to long-term resistance exercise. Med. Sci. Sports Exerc. 35, 944–951. doi:10.1249/01.MSS.0000069756.17841.9E
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Trappe S.,
    2. Harber M.,
    3. Creer A.,
    4. Gallagher P.,
    5. Slivka D.,
    6. Minchev K.,
    7. Whitsett D.
    (2006). Single muscle fiber adaptations with marathon training. J. Appl. Physiol. 101, 721–727. doi:10.1152/japplphysiol.01595.2005
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. van Adel B. A.,
    2. Tarnopolsky M. A.
    (2009). Metabolic myopathies: update 2009. J. Clin. Neuromuscul. Dis. 10, 97–121. doi:10.1097/CND.0b013e3181903126
    OpenUrlCrossRefPubMed
  32. ↵
    1. von Tscharner V.,
    2. Nigg B. M.
    (2008). Point:Counterpoint: Spectral properties of the surface EMG can characterize/do not provide information about motor unit recruitment strategies and muscle fiber type. J. Appl. Physiol. 105, 1671–1673. doi:10.1152/japplphysiol.90598.2008
    OpenUrlFREE Full Text
  33. ↵
    1. Williams D. A.,
    2. Head S. I.,
    3. Lynch G. S.,
    4. Stephenson D. G.
    (1993). Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. J. Physiol. 460, 51–67.
    OpenUrlPubMedWeb of Science
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Myosin heavy chain
  • Glycogen storage disease V
  • Phosphorylase deficiency

 Download PDF

Email

Thank you for your interest in spreading the word on Biology Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
McArdle disease does not affect skeletal muscle fibre type profiles in humans
(Your Name) has sent you a message from Biology Open
(Your Name) thought you would like to see the Biology Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
McArdle disease does not affect skeletal muscle fibre type profiles in humans
Tertius Abraham Kohn, Timothy David Noakes, Dale Elizabeth Rae, Juan Carlos Rubio, Alfredo Santalla, Gisela Nogales-Gadea, Tomas Pinós, Miguel A. Martín, Joaquin Arenas, Alejandro Lucia
Biology Open 2014 3: 1224-1227; doi: 10.1242/bio.20149548
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
McArdle disease does not affect skeletal muscle fibre type profiles in humans
Tertius Abraham Kohn, Timothy David Noakes, Dale Elizabeth Rae, Juan Carlos Rubio, Alfredo Santalla, Gisela Nogales-Gadea, Tomas Pinós, Miguel A. Martín, Joaquin Arenas, Alejandro Lucia
Biology Open 2014 3: 1224-1227; doi: 10.1242/bio.20149548

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article Navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS AND DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Funding
    • Footnotes
    • REFERENCES
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF

Related articles

Cited by...

More in this TOC section

  • Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
  • Segregation of brain and organizer precursors is differentially regulated by Nodal signaling at blastula stage
  • Unique histological features of the tail skin of cotton rat (Sigmodon hispidus) related to caudal autotomy
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Advertisement

Biology Open and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


New funding scheme supports sustainable events

As part of our Sustainable Conferencing Initiative, we are pleased to announce funding for organisers that seek to reduce the environmental footprint of their event. The next deadline to apply for a Scientific Meeting grant is 26 March 2021.


Future Leader Review – early neurodegeneration of Alzheimer’s disease

A new Future Leader Review from Olayemi Olajide, Marcus Suvanto and Clifton Andrew Chapman evaluates the molecular mechanisms that may explain the vulnerability and susceptibility of the entorhinal cortex to early neurodegeneration during the pathogenesis of Alzheimer's disease.

Find out more about our Future Leader Reviews – they are an exclusive opportunity for early-career researchers who want to establish themselves in their field.


First author interviews

Catch up on our latest first author interviews to go behind the scenes of our latest research, find out more about the authors and hear from early-career researchers themselves how they’re finding life at the bench.


Retinal degeneration in Drosophila

Thank you to Elisabeth Knust and her team for their confocal image of a longitudinal section of an adult Drosophila retina, which brightens the cover of our latest issue. Read the research behind the cover.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Interviews
  • Sign up for alerts

About us

  • About BiO
  • Editors and Board
  • Editor biographies
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact BiO
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992